Lab
Alcala Pharmaceutical INC.
Alcala Pharmaceutical INC. was paid $346K by Medicaid between Jan 2018 and Jul 2022, across 71 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 32% of everything it billed.
33Billing provider infoALCALA PHARMACEUTICAL INC.
SAN DIEGO, CA 92108
SAN DIEGO, CA 92108
33aNPI1255656153assigned 04/02/2010
33bProvider typeClinical Medical Laboratory
28Total paid$346K
24GClaims24,330
24DCodes billed71
24AFirst – last monthJan 2018 – Jul 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#256 of 561
Median peer was paid$222K
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SMITH, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,869 | $72K | |
| 2019 | 4,690 | $73K | |
| 2020 | 2,983 | $48K | |
| 2021 | 7,902 | $149K | |
| 2022 | 886 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 32% | 6,419 | 4,456 | $112K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 22% | 5,352 | 4,582 | $75K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 21% | 6,320 | 5,422 | $72K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 18% | 1,090 | 789 | $61K |
| 86328 | 3.5% | 574 | 452 | $12K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.3% | 721 | 681 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 88 | 79 | $557.59 |
| 80323 | <1% | 27 | 27 | $539.22 | |
| 80346 | <1% | 53 | 53 | $477.20 | |
| 80332 | <1% | 53 | 53 | $422.43 | |
| 80338 | <1% | 52 | 52 | $422.43 | |
| 80336 | <1% | 52 | 52 | $422.43 |
59 more codes
| 80343 | <1% | 52 | $373.03 | |
| 80348 | <1% | 27 | $317.80 | |
| 80324 | <1% | 39 | $315.17 | |
| 80061 | Lipid panel | <1% | 48 | $299.47 |
| 82728 | <1% | 43 | $281.18 | |
| 80358 | <1% | 27 | $270.51 | |
| 80345 | <1% | 27 | $242.31 | |
| 83520 | <1% | 83 | $232.50 | |
| 80353 | <1% | 27 | $222.66 | |
| 84466 | <1% | 43 | $214.52 | |
| 80349 | <1% | 27 | $207.99 | |
| 80355 | <1% | 39 | $206.63 | |
| 86769 | <1% | 30 | $202.23 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 53 | $199.18 |
| 80329 | <1% | 53 | $193.11 | |
| 80321 | <1% | 27 | $178.42 | |
| 80361 | <1% | 52 | $160.40 | |
| 80359 | <1% | 27 | $142.34 | |
| 84481 | <1% | 193 | $117.24 | |
| 84403 | <1% | 36 | $115.13 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 103 | $112.56 |
| 82746 | <1% | 220 | $109.17 | |
| 82607 | <1% | 149 | $107.56 | |
| 83090 | <1% | 95 | $95.22 | |
| 80053 | Comprehensive metabolic panel | <1% | 159 | $93.44 |
| 84681 | <1% | 61 | $90.75 | |
| 83525 | <1% | 131 | $86.99 | |
| 83540 | <1% | 22 | $80.24 | |
| 82172 | <1% | 93 | $71.86 | |
| 83695 | <1% | 62 | $69.68 | |
| 80373 | <1% | 27 | $63.56 | |
| 84439 | <1% | 182 | $62.09 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 141 | $58.36 |
| 86141 | <1% | 61 | $56.84 | |
| 80368 | <1% | 39 | $56.53 | |
| 80366 | <1% | 39 | $56.53 | |
| 86160 | <1% | 61 | $53.21 | |
| 80352 | <1% | 27 | $45.92 | |
| 83615 | <1% | 120 | $41.14 | |
| 83992 | <1% | 27 | $39.84 | |
| 80177 | <1% | 27 | $36.18 | |
| 80203 | <1% | 27 | $36.18 | |
| 80183 | <1% | 27 | $36.12 | |
| 82150 | <1% | 94 | $36.05 | |
| 80178 | <1% | 61 | $30.06 | |
| 80155 | <1% | 39 | $28.93 | |
| 86431 | <1% | 61 | $25.37 | |
| 81003 | <1% | 20 | $6.30 | |
| 84252 | 0% | 40 | $0.00 | |
| 84591 | 0% | 40 | $0.00 | |
| 84446 | 0% | 40 | $0.00 | |
| 80199 | 0% | 27 | $0.00 | |
| 84425 | 0% | 40 | $0.00 | |
| 84207 | 0% | 40 | $0.00 | |
| 82180 | 0% | 40 | $0.00 | |
| 80175 | 0% | 27 | $0.00 | |
| 84597 | 0% | 40 | $0.00 | |
| 80159 | 0% | 27 | $0.00 | |
| 84590 | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, DAVID (MD)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.